Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 14 | 2024 | 3792 | 2.020 |
Why?
|
RNA, Small Interfering | 11 | 2019 | 3427 | 1.550 |
Why?
|
Nanoparticles | 12 | 2017 | 1966 | 1.330 |
Why?
|
Islets of Langerhans Transplantation | 10 | 2015 | 748 | 1.220 |
Why?
|
Islets of Langerhans | 12 | 2017 | 1350 | 1.140 |
Why?
|
Doxorubicin | 5 | 2017 | 2229 | 1.120 |
Why?
|
Molecular Imaging | 6 | 2017 | 822 | 1.110 |
Why?
|
Oligonucleotides | 3 | 2020 | 561 | 1.010 |
Why?
|
Carbocyanines | 6 | 2024 | 177 | 0.940 |
Why?
|
Magnetic Resonance Imaging | 26 | 2024 | 36582 | 0.760 |
Why?
|
Ferric Compounds | 5 | 2016 | 376 | 0.740 |
Why?
|
RNA Interference | 5 | 2021 | 2829 | 0.740 |
Why?
|
Magnetite Nanoparticles | 5 | 2019 | 310 | 0.710 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2017 | 1121 | 0.680 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17097 | 0.670 |
Why?
|
Pancreas | 5 | 2019 | 1699 | 0.640 |
Why?
|
Biosensing Techniques | 2 | 2016 | 641 | 0.630 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2019 | 123 | 0.620 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21178 | 0.560 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2019 | 645 | 0.540 |
Why?
|
Mucin-1 | 6 | 2016 | 536 | 0.530 |
Why?
|
Drug Carriers | 2 | 2019 | 702 | 0.520 |
Why?
|
Neoplastic Stem Cells | 2 | 2024 | 1349 | 0.520 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2016 | 52 | 0.510 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2013 | 200 | 0.490 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 754 | 0.470 |
Why?
|
Spectroscopy, Near-Infrared | 4 | 2009 | 749 | 0.470 |
Why?
|
Chickens | 3 | 2015 | 843 | 0.460 |
Why?
|
Mice | 45 | 2024 | 81912 | 0.460 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2824 | 0.450 |
Why?
|
Microscopy, Fluorescence | 9 | 2016 | 2628 | 0.430 |
Why?
|
Nanocapsules | 1 | 2014 | 92 | 0.430 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3608 | 0.410 |
Why?
|
Cell Movement | 4 | 2024 | 5203 | 0.410 |
Why?
|
Adenocarcinoma | 5 | 2013 | 6360 | 0.390 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 678 | 0.380 |
Why?
|
Magnetics | 2 | 2012 | 586 | 0.380 |
Why?
|
Animals | 52 | 2024 | 168965 | 0.370 |
Why?
|
Neoplasms, Experimental | 2 | 2014 | 1228 | 0.370 |
Why?
|
Subrenal Capsule Assay | 1 | 2009 | 27 | 0.330 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8628 | 0.330 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5446 | 0.330 |
Why?
|
Oxides | 3 | 2009 | 402 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2010 | 3449 | 0.310 |
Why?
|
Spectrum Analysis, Raman | 1 | 2010 | 250 | 0.310 |
Why?
|
Drug Delivery Systems | 5 | 2017 | 2212 | 0.310 |
Why?
|
Neoplasm Metastasis | 5 | 2024 | 4892 | 0.300 |
Why?
|
Brain Neoplasms | 5 | 2024 | 9108 | 0.290 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1759 | 0.290 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18330 | 0.290 |
Why?
|
Isoantigens | 2 | 2015 | 562 | 0.290 |
Why?
|
Neoplasms | 7 | 2020 | 22350 | 0.290 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 400 | 0.290 |
Why?
|
Iron | 5 | 2014 | 1811 | 0.270 |
Why?
|
Gene Expression | 2 | 2016 | 7587 | 0.260 |
Why?
|
Zinc | 1 | 2010 | 675 | 0.260 |
Why?
|
Apoptosis | 6 | 2019 | 9513 | 0.250 |
Why?
|
Nanostructures | 1 | 2010 | 549 | 0.250 |
Why?
|
Insulin-Secreting Cells | 2 | 2011 | 898 | 0.250 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1074 | 0.240 |
Why?
|
Dextrans | 5 | 2024 | 574 | 0.240 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2118 | 0.230 |
Why?
|
Cell Proliferation | 5 | 2024 | 10455 | 0.220 |
Why?
|
Eimeria tenella | 1 | 2003 | 3 | 0.220 |
Why?
|
Coccidiosis | 1 | 2003 | 10 | 0.220 |
Why?
|
Poultry Diseases | 1 | 2003 | 24 | 0.220 |
Why?
|
Mice, Nude | 6 | 2016 | 3618 | 0.220 |
Why?
|
Cecal Diseases | 1 | 2003 | 49 | 0.220 |
Why?
|
Peptides | 6 | 2012 | 4348 | 0.210 |
Why?
|
Immunotherapy | 1 | 2019 | 4745 | 0.210 |
Why?
|
Mucins | 1 | 2006 | 569 | 0.210 |
Why?
|
Sarcoma, Avian | 1 | 2002 | 3 | 0.200 |
Why?
|
Microcirculation | 1 | 2007 | 1282 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 3 | 2024 | 462 | 0.200 |
Why?
|
Fluorescence | 3 | 2017 | 751 | 0.190 |
Why?
|
Gene Silencing | 2 | 2010 | 1505 | 0.190 |
Why?
|
Staining and Labeling | 1 | 2006 | 1076 | 0.190 |
Why?
|
Contrast Media | 8 | 2016 | 5329 | 0.190 |
Why?
|
Models, Biological | 1 | 2017 | 9464 | 0.180 |
Why?
|
Histocompatibility Antigens | 1 | 2002 | 479 | 0.180 |
Why?
|
Fluorescent Dyes | 5 | 2017 | 1928 | 0.180 |
Why?
|
Hyperglycemia | 2 | 2008 | 1388 | 0.180 |
Why?
|
Cell Survival | 3 | 2020 | 5750 | 0.170 |
Why?
|
Gadolinium | 3 | 2012 | 964 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2024 | 496 | 0.170 |
Why?
|
Fluorescein-5-isothiocyanate | 2 | 2011 | 220 | 0.170 |
Why?
|
Diagnostic Imaging | 3 | 2009 | 3530 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11872 | 0.160 |
Why?
|
Gadolinium DTPA | 2 | 2012 | 823 | 0.160 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.160 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6226 | 0.150 |
Why?
|
Female | 28 | 2024 | 396660 | 0.150 |
Why?
|
Molecular Probes | 3 | 2009 | 309 | 0.150 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3611 | 0.150 |
Why?
|
Graft Rejection | 4 | 2015 | 4498 | 0.150 |
Why?
|
Humans | 42 | 2024 | 767040 | 0.150 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 719 | 0.140 |
Why?
|
Liver Transplantation | 1 | 2009 | 2416 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2014 | 5891 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 896 | 0.130 |
Why?
|
Avian Proteins | 1 | 2015 | 77 | 0.120 |
Why?
|
Glioblastoma | 2 | 2024 | 3461 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4648 | 0.120 |
Why?
|
Indocyanine Green | 1 | 2017 | 237 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2019 | 886 | 0.110 |
Why?
|
Nanomedicine | 1 | 2017 | 289 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2016 | 342 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1331 | 0.110 |
Why?
|
Infrared Rays | 2 | 2005 | 249 | 0.110 |
Why?
|
Base Pairing | 1 | 2014 | 139 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13650 | 0.110 |
Why?
|
Mice, Inbred NOD | 5 | 2012 | 1837 | 0.110 |
Why?
|
Cell-Free System | 1 | 2014 | 339 | 0.110 |
Why?
|
Ribonucleases | 1 | 2014 | 266 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2019 | 963 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 8940 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 804 | 0.100 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6550 | 0.100 |
Why?
|
Streptozocin | 2 | 2015 | 189 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6106 | 0.100 |
Why?
|
Dacarbazine | 1 | 2014 | 552 | 0.100 |
Why?
|
Chelating Agents | 2 | 2010 | 384 | 0.090 |
Why?
|
Biological Availability | 1 | 2012 | 387 | 0.090 |
Why?
|
Sphingomyelins | 1 | 2011 | 104 | 0.090 |
Why?
|
Salts | 1 | 2010 | 60 | 0.090 |
Why?
|
Ferrosoferric Oxide | 2 | 2009 | 348 | 0.090 |
Why?
|
Blotting, Western | 3 | 2012 | 5022 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9551 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2050 | 0.090 |
Why?
|
Drug Stability | 1 | 2010 | 289 | 0.090 |
Why?
|
Fluorine Compounds | 1 | 2009 | 7 | 0.090 |
Why?
|
Transfection | 2 | 2016 | 5753 | 0.090 |
Why?
|
Particle Size | 1 | 2014 | 1633 | 0.080 |
Why?
|
Fibrin | 1 | 2012 | 514 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 2012 | 879 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1903 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1045 | 0.080 |
Why?
|
Curcumin | 1 | 2009 | 97 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2015 | 3076 | 0.080 |
Why?
|
Image Enhancement | 2 | 2010 | 2867 | 0.080 |
Why?
|
Mice, SCID | 3 | 2012 | 2626 | 0.070 |
Why?
|
Boron Compounds | 1 | 2009 | 195 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1154 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3567 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11097 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2900 | 0.070 |
Why?
|
Papio | 1 | 2009 | 672 | 0.070 |
Why?
|
Pentetic Acid | 1 | 2007 | 209 | 0.070 |
Why?
|
Cell Cycle | 1 | 2015 | 2927 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2012 | 22361 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6966 | 0.070 |
Why?
|
Gold | 1 | 2010 | 482 | 0.070 |
Why?
|
Lymphocytes | 2 | 2015 | 2605 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1604 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3944 | 0.060 |
Why?
|
Antigens | 1 | 2011 | 1442 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2006 | 111 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 934 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2931 | 0.060 |
Why?
|
Annexin A5 | 1 | 2005 | 102 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1097 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3813 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2005 | 151 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2391 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5332 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2006 | 305 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 825 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11217 | 0.060 |
Why?
|
Liposomes | 1 | 2008 | 787 | 0.060 |
Why?
|
Breast | 1 | 2012 | 1972 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13411 | 0.050 |
Why?
|
Disease Progression | 2 | 2012 | 13646 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2010 | 1377 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2063 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1429 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17608 | 0.050 |
Why?
|
Coloring Agents | 1 | 2005 | 565 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5924 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2009 | 1467 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2121 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1361 | 0.050 |
Why?
|
Angiography | 1 | 2007 | 1597 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11063 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8535 | 0.050 |
Why?
|
Fluorouracil | 1 | 2006 | 1652 | 0.050 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 1969 | 0.040 |
Why?
|
Water | 1 | 2005 | 1419 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 1029 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2702 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9245 | 0.040 |
Why?
|
Rats | 2 | 2011 | 23713 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2890 | 0.040 |
Why?
|
Insulin | 2 | 2011 | 6602 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1997 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2017 | 2275 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20169 | 0.040 |
Why?
|
Blood Glucose | 2 | 2015 | 6421 | 0.040 |
Why?
|
Graft Survival | 1 | 2008 | 3896 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16718 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2255 | 0.030 |
Why?
|
Indoles | 1 | 2005 | 1836 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1791 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 3114 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 3886 | 0.030 |
Why?
|
Glycosylation | 2 | 2012 | 1099 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2015 | 32 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3236 | 0.030 |
Why?
|
Haplotypes | 1 | 2002 | 2722 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 2014 | 30 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3502 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4572 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
Kidney | 1 | 2009 | 7063 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 65295 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5141 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 12250 | 0.030 |
Why?
|
Molecular Structure | 2 | 2009 | 1882 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2360 | 0.030 |
Why?
|
Sialyltransferases | 1 | 2012 | 83 | 0.030 |
Why?
|
Neuraminidase | 1 | 2012 | 192 | 0.020 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2012 | 174 | 0.020 |
Why?
|
Fumonisins | 1 | 2011 | 10 | 0.020 |
Why?
|
Chromatography | 1 | 2011 | 189 | 0.020 |
Why?
|
Toxins, Biological | 1 | 2011 | 59 | 0.020 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 67 | 0.020 |
Why?
|
Cell Line | 3 | 2011 | 15567 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3804 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 545 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9517 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11923 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2010 | 71 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2264 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5886 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 167 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1697 | 0.020 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 117 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 280 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 13035 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 730 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14672 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 568 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1188 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 29963 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4838 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2411 | 0.020 |
Why?
|
Male | 4 | 2016 | 364203 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2006 | 697 | 0.020 |
Why?
|
beta-Alanine | 1 | 2005 | 82 | 0.010 |
Why?
|
Acute Disease | 1 | 2015 | 7236 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1965 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2005 | 475 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1078 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27163 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2005 | 694 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4210 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2551 | 0.010 |
Why?
|
Astrocytes | 1 | 2010 | 1352 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 1531 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3154 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5311 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2428 | 0.010 |
Why?
|
Polymers | 1 | 2008 | 1624 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3726 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3322 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 18063 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40154 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9327 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12414 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15424 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12823 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12793 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1806 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3582 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2487 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6001 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18989 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11657 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39317 | 0.010 |
Why?
|